If you are having trouble viewing this email, view online version .

ESE News Alert - 04 September 2020

Early puberty may increase breast cancer risk

According to a study published in the Journal of Adolescent Health, girls who start puberty earlier than average, due to higher levels of growth hormone, may have an increased risk of developing breast cancer as adults.

News Medical


New drug approved by FDA for treating growth hormone deficiency

The new drug, somapacitan, has been approved by the US Food and Drug Administration as a replacement growth hormone in adults with growth hormone deficiency and is the first drug that can be administered weekly, rather than daily.

Medscape


Experts discuss the links between COVID-19 and endocrinology

The role of the endocrine system in COVID-19 infection is being discussed by three endocrine experts during the European Society of Endocrinology’s virtual Congress, e-ECE 2020, on 8 September.

News Medical


Blood hormone may help predict risk of heart disease

A blood test to identify high levels of the hormone, C-type Natriuretic Peptide (CNP), may help predict risk of heart disease, according to a study published in the journal Peptides.

Medical Xpress


The European Society of Endocrinology is Europe’s premier learned society promoting research, education and clinical practice in endocrinology for the public benefit and representing doctors and scientists who work in endocrinology. For more information, visit http://www.ese-hormones.org/

This news alert is designed to provide European Society of Endocrinology (ESE) members with a summary of stories on endocrinology currently appearing in the media. The views expressed in the stories featured in this update are not necessarily those of the ESE. The ESE accepts no responsibility for the accuracy or completeness of the material contained in this alert.

If you know of some European media coverage that would be of interest to the ESE membership, please contact the ESE press office.

Please note that the address that sent this email is not monitored and we cannot respond to direct replies.

Stay connected

;